How are Foresight Autonomous Ordinary Shares related to ADS for FRSX?

Foresight Autonomous securities trade as American Depository Shares (ADS), where one ADS represents 90 Ordinary Shares. Each ADS is convertible into Ordinary Shares at the holder’s election and has no expiration date, providing a flexible structure for U.S. investors.

Foresight CTO discloses 64,286 option shares

Q: What does the FRSX Form 3 filing by Zruya Levy show?

The Form 3 shows Chief Technology Officer Zruya Levy’s initial beneficial ownership in stock options. It details two vested option grants over Foresight Autonomous Ordinary Shares, including exercise prices, share amounts, and expiration dates, without reporting any new purchases or sales.

Q: How many Foresight Autonomous shares can Zruya Levy acquire under these options?

Zruya Levy can acquire a total of 64,286 Ordinary Shares through vested stock options. These represent 21,429 shares expiring in 2027 and 42,857 shares expiring in 2028, all at an exercise price of 1.120 per underlying Ordinary Share.

Q: What are the exercise terms of Zruya Levy’s FRSX stock options?

Both option grants carry an exercise price of 1.120 per share for Foresight Autonomous Ordinary Shares. The options were originally granted at NIS 3.50 and converted using a 3.119 ratio as of March 16, 2026, with all grants fully vested.

Q: When do Zruya Levy’s stock options in FRSX expire?

Zruya Levy’s vested stock options expire on two dates: July 16, 2027, for 21,429 underlying Ordinary Shares, and August 27, 2028, for 42,857 underlying Ordinary Shares. After these dates, any unexercised options from these grants will lapse.

Foresight Autonomous Holdings Ltd. disclosed the initial holdings of Chief Technology Officer Zruya Levy on a Form 3.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Foresight Autonomous Holdings Ltd. disclosed the initial holdings of Chief Technology Officer Zruya Levy on a Form 3. Levy holds vested stock options to acquire 21,429 Ordinary Shares at an exercise price of 1.120 per share expiring on July 16, 2027, and 42,857 Ordinary Shares at the same exercise price expiring on August 27, 2028. The options granted in 2019 and 2020 are fully vested, and the issuer’s securities also trade as American Depository Shares, where one ADS represents 90 Ordinary Shares and is convertible at any time.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Zruya Levy

Role Chief Technology Officer

Type	Security	Shares	Price	Value
holding	Stock Options (Right to buy)	--	--	--
holding	Stock Options (Right to buy)	--	--	--

Holdings After Transaction: Stock Options (Right to buy) — 64,286 contracts (Direct)

Footnotes (5)

F1. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.
F2. The options were granted on July 16, 2020 and fully vested as of December 31, 2022.
F3. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.
F4. The options were granted on August 27,2019 and fully vested as of December 31, 2019.
F5. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

Key Figures

Vested option underlying shares (2027): 21,429 Ordinary Shares Vested option underlying shares (2028): 42,857 Ordinary Shares Total underlying shares: 64,286 Ordinary Shares +3 more

6 metrics

Vested option underlying shares (2027) 21,429 Ordinary Shares Underlying shares for options expiring July 16, 2027

Vested option underlying shares (2028) 42,857 Ordinary Shares Underlying shares for options expiring August 27, 2028

Total underlying shares 64,286 Ordinary Shares Combined underlying shares from both option grants

Option exercise price 1.120 per share Exercise price for both option grants after conversion

Original grant exercise price NIS 3.50 Original exercise price before 3.119 conversion ratio

ADS to Ordinary Share ratio 1 ADS = 90 Ordinary Shares Structure of Foresight Autonomous American Depository Shares

Key Terms

Stock Options (Right to buy), Ordinary Shares, American Depository Shares ("ADS"), exercise price, +1 more

5 terms

Stock Options (Right to buy) financial

"security_title: "Stock Options (Right to buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

American Depository Shares ("ADS") financial

"The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares."

exercise price financial

"The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

fully vested financial

"The options were granted on July 16, 2020 and fully vested as of December 31, 2022."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the FRSX Form 3 filing by Zruya Levy show?

The Form 3 shows Chief Technology Officer Zruya Levy’s initial beneficial ownership in stock options. It details two vested option grants over Foresight Autonomous Ordinary Shares, including exercise prices, share amounts, and expiration dates, without reporting any new purchases or sales.

How many Foresight Autonomous shares can Zruya Levy acquire under these options?

Zruya Levy can acquire a total of 64,286 Ordinary Shares through vested stock options. These represent 21,429 shares expiring in 2027 and 42,857 shares expiring in 2028, all at an exercise price of 1.120 per underlying Ordinary Share.

What are the exercise terms of Zruya Levy’s FRSX stock options?

Both option grants carry an exercise price of 1.120 per share for Foresight Autonomous Ordinary Shares. The options were originally granted at NIS 3.50 and converted using a 3.119 ratio as of March 16, 2026, with all grants fully vested.

When do Zruya Levy’s stock options in FRSX expire?

Zruya Levy’s vested stock options expire on two dates: July 16, 2027, for 21,429 underlying Ordinary Shares, and August 27, 2028, for 42,857 underlying Ordinary Shares. After these dates, any unexercised options from these grants will lapse.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/13/2026 - 09:17 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zruya Levy

(Last)

(First)

(Middle)

C/O FORESIGHT AUTONOMOUS

7 GOLDA MEIR ISRAEL

(Street)

NESS ZIONA

7414001

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Foresight Autonomous Holdings Ltd. [ FRSX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Technology Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to buy)	⁽²⁾	07/16/2027	Ordinary Shares⁽¹⁾	21,429	$1.12⁽³⁾	D
Stock Options (Right to buy)	⁽⁴⁾	08/27/2028	Ordinary Shares	42,857	$1.12⁽⁵⁾	D

Explanation of Responses:

1. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.

2. The options were granted on July 16, 2020 and fully vested as of December 31, 2022.

3. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

4. The options were granted on August 27,2019 and fully vested as of December 31, 2019.

5. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

	/s/ Levy Zruya	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR